GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Revenio Group Oyj (FRA:R0V) » Definitions » EV-to-EBITDA

Revenio Group Oyj (FRA:R0V) EV-to-EBITDA : 23.93 (As of May. 10, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Revenio Group Oyj EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Revenio Group Oyj's enterprise value is €702.48 Mil. Revenio Group Oyj's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €29.35 Mil. Therefore, Revenio Group Oyj's EV-to-EBITDA for today is 23.93.

The historical rank and industry rank for Revenio Group Oyj's EV-to-EBITDA or its related term are showing as below:

FRA:R0V' s EV-to-EBITDA Range Over the Past 10 Years
Min: 13.39   Med: 31.18   Max: 75.23
Current: 23.93

During the past 13 years, the highest EV-to-EBITDA of Revenio Group Oyj was 75.23. The lowest was 13.39. And the median was 31.18.

FRA:R0V's EV-to-EBITDA is ranked worse than
68.53% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 16.52 vs FRA:R0V: 23.93

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-10), Revenio Group Oyj's stock price is €26.88. Revenio Group Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €0.697. Therefore, Revenio Group Oyj's PE Ratio for today is 38.57.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Revenio Group Oyj EV-to-EBITDA Historical Data

The historical data trend for Revenio Group Oyj's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revenio Group Oyj EV-to-EBITDA Chart

Revenio Group Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.08 61.93 56.85 30.96 23.93

Revenio Group Oyj Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.95 26.52 17.71 23.93 22.41

Competitive Comparison of Revenio Group Oyj's EV-to-EBITDA

For the Medical Devices subindustry, Revenio Group Oyj's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's EV-to-EBITDA falls into.



Revenio Group Oyj EV-to-EBITDA Calculation

Revenio Group Oyj's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=702.479/29.353
=23.93

Revenio Group Oyj's current Enterprise Value is €702.48 Mil.
Revenio Group Oyj's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €29.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Revenio Group Oyj  (FRA:R0V) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Revenio Group Oyj's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=26.88/0.697
=38.57

Revenio Group Oyj's share price for today is €26.88.
Revenio Group Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.697.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Revenio Group Oyj EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Revenio Group Oyj's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Revenio Group Oyj (FRA:R0V) Business Description

Traded in Other Exchanges
Address
Ayritie 22, Vantaa, FIN, 01510
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.

Revenio Group Oyj (FRA:R0V) Headlines

No Headlines